- Home
- RXRX vs CDP Comparison
RXRX vs CDP Comparison
Compare RXRX & CDP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RXRX
- CDP
- Stock Information
- Founded
- RXRX 2013
- CDP 1988
- Country
- RXRX United States
- CDP United States
- Employees
- RXRX N/A
- CDP N/A
- Industry
- RXRX Biotechnology: Pharmaceutical Preparations
- CDP Real Estate Investment Trusts
- Sector
- RXRX Health Care
- CDP Real Estate
- Exchange
- RXRX Nasdaq
- CDP Nasdaq
- Market Cap
- RXRX 2.6B
- CDP 3.0B
- IPO Year
- RXRX 2021
- CDP N/A
- Fundamental
- Price
- RXRX $4.33
- CDP $26.79
- Analyst Decision
- RXRX Buy
- CDP Buy
- Analyst Count
- RXRX 5
- CDP 6
- Target Price
- RXRX $7.60
- CDP $33.83
- AVG Volume (30 Days)
- RXRX 22.1M
- CDP 855.3K
- Earning Date
- RXRX 05-05-2025
- CDP 04-28-2025
- Dividend Yield
- RXRX N/A
- CDP 4.57%
- EPS Growth
- RXRX N/A
- CDP N/A
- EPS
- RXRX N/A
- CDP 1.24
- Revenue
- RXRX $59,790,000.00
- CDP $748,556,000.00
- Revenue This Year
- RXRX $57.30
- CDP N/A
- Revenue Next Year
- RXRX $51.53
- CDP $5.55
- P/E Ratio
- RXRX N/A
- CDP $21.43
- Revenue Growth
- RXRX 29.32
- CDP 5.34
- 52 Week Low
- RXRX $3.79
- CDP $23.47
- 52 Week High
- RXRX $12.36
- CDP $34.22
- Technical
- Relative Strength Index (RSI)
- RXRX 36.37
- CDP 54.41
- Support Level
- RXRX $4.11
- CDP $25.99
- Resistance Level
- RXRX $5.90
- CDP $26.65
- Average True Range (ATR)
- RXRX 0.39
- CDP 0.56
- MACD
- RXRX -0.11
- CDP 0.09
- Stochastic Oscillator
- RXRX 11.00
- CDP 81.03
About RXRX Recursion Pharmaceuticals Inc.
Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. It is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery.
About CDP COPT Defense Properties of Beneficial Interest
COPT Defense Properties is a real estate investment trust that acquires, manages, and leases office and data center properties throughout the U.S. The majority of the company's real estate portfolio is composed of office buildings in the Baltimore-Washington Corridor and Northern Virginia area. COPT derives nearly all of its income in the form of rental revenue from tenants. Most of the company's revenue comes from the leasing of properties to U.S. Government agencies and its contractors in the national security, defense, and IT sectors, such as Northrop Grumman and Boeing. Regional offices in urban submarkets make also make up a sizable percentage of COPT's total square footage.